Found 17 matching trials
Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula Polymorpha)
PHASE3The purpose of this study is to evaluate the Efficacy, Safety and Immunogen...
Location
Laishui County Center for Disease Control and Prevention
Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines
PHASE1VXA-NVV-103 is a phase 1B Randomized, Double-Blind, Placebo-Controlled, Mul...
Location
Rapid Medical Research
Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine
PHASE2The purpose of this study is to collect serum samples to evaluate serologic...
Location
Benchmark Research Austin
Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants
PHASE1This is a phase 1, randomized, double-blind multi-center, placebo-controlle...
Location
Fukui Aiiku Hospital
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
PHASE2The purpose of this study is to evaluate the efficacy of the Norovirus (NoV...
Location
Great Lakes Naval Station
Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults
PHASE2The purpose of this study is to evaluate the safety of the norovirus bivale...
Location
California Research Foundation
Recombinant, Bivalent, Norovirus Vaccine Study
PHASE1This clinical study will evaluate the vaccine candidate rNV-2v, which is un...
Location
Center for Vaccinology (CEVAC), Ghent University and University Hospital
Bivalent Norovirus Vaccine Study
PHASE1Randomized, multi-site, dose-escalation study of the safety and immunogenic...
Location
Navy Medical Research Center
A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine
PHASE1A total of 450 subjects were enrolled, divided into four age groups, includ...
Location
qixian Center for Disease Control and Prevention
A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old
PHASE1The primary objective of this study is to determine the safety and immunoge...
Location
Johnson County Clin Trials - JCCT